| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 719,9 k € | +6.7% | 674,9 k € | +11.0% | 607,8 k € | +6.5% | 570,8 k € | -1.0% | 576,8 k € | -10.9% | 647,4 k € | +10.8% | 584,2 k € | +7.9% | 541,6 k € | -25.4% | 725,9 k € | -4.1% | 756,9 k € | +59.0% | 476,2 k € | +6.0% | 449,2 k € | +15.3% | 389,5 k € | -10.3% | 434,4 k € | +2.1% | 425,6 k € | |
| EBITDA | 706,6 k € | +8.1% | 653,9 k € | +11.4% | 586,7 k € | +11.5% | 526,3 k € | -1.4% | 533,9 k € | -11.6% | 604,0 k € | +9.3% | 552,8 k € | +7.9% | 512,2 k € | -25.7% | 689,7 k € | -3.5% | 714,7 k € | +65.8% | 431,1 k € | +6.9% | 403,3 k € | +18.1% | 341,5 k € | -11.7% | 387,0 k € | -7.7% | 419,2 k € | |
| Operating profit | 683,5 k € | +8.3% | 631,1 k € | +11.7% | 565,0 k € | +10.3% | 512,3 k € | -1.5% | 520,2 k € | -9.8% | 576,6 k € | +9.5% | 526,4 k € | +6.6% | 493,6 k € | -25.5% | 662,1 k € | -3.6% | 687,2 k € | +68.2% | 408,6 k € | +7.8% | 378,9 k € | +17.1% | 323,6 k € | -14.2% | 377,3 k € | -8.5% | 412,1 k € | |
| Profit/loss | 654,4 k € | +49.2% | 438,6 k € | +3.7% | 422,9 k € | +12.0% | 377,4 k € | -0.7% | 380,1 k € | +0.2% | 379,2 k € | +10.0% | 344,9 k € | +16.5% | 296,1 k € | -26.2% | 401,1 k € | -3.6% | 416,0 k € | +68.6% | 246,7 k € | -0.8% | 248,6 k € | +15.5% | 215,3 k € | -13.7% | 249,4 k € | -7.8% | 270,5 k € | |
| Equity | 2,7 M € | +13.2% | 2,4 M € | +6.4% | 2,2 M € | +1.0% | 2,2 M € | -1.7% | 2,2 M € | +6.3% | 2,1 M € | +22.0% | 1,7 M € | +25.0% | 1,4 M € | +27.3% | 1,1 M € | +58.7% | 683,2 k € | +155.7% | 267,2 k € | +1206.0% | 20,5 k € | 0.0% | 20,5 k € | 0.0% | 20,5 k € | 0.0% | 20,5 k € | |
| Total assets | 2,8 M € | +11.3% | 2,5 M € | +4.3% | 2,4 M € | +3.5% | 2,3 M € | -2.3% | 2,4 M € | +8.9% | 2,2 M € | +23.4% | 1,8 M € | +24.5% | 1,4 M € | +24.7% | 1,1 M € | +41.7% | 797,8 k € | +128.5% | 349,1 k € | +5.9% | 329,7 k € | -16.6% | 395,4 k € | -34.1% | 599,7 k € | +16.7% | 513,8 k € | |
| Cash | 49,9 k € | +7.6% | 46,4 k € | -76.8% | 199,8 k € | +24.6% | 160,3 k € | +17.5% | 136,5 k € | -60.5% | 345,9 k € | -48.7% | 674,3 k € | +15.3% | 584,9 k € | +33.5% | 438,2 k € | -9.8% | 486,1 k € | +146.6% | 197,1 k € | -17.8% | 239,8 k € | -10.8% | 268,8 k € | -48.1% | 517,6 k € | +10.3% | 469,5 k € | |
| Debts | 94,3 k € | -24.0% | 124,2 k € | -24.4% | 164,3 k € | +56.1% | 105,3 k € | -12.9% | 120,9 k € | +97.4% | 61,3 k € | +101.0% | 30,5 k € | +3.9% | 29,3 k € | -36.7% | 46,4 k € | -59.5% | 114,5 k € | +39.9% | 81,9 k € | -73.5% | 309,3 k € | -17.5% | 375,0 k € | -35.3% | 579,2 k € | +17.4% | 493,4 k € | |
| Staff | 0,3 | 0,3 | 0,3 | 0,9 | 1 | 1 | 0,7 | 0,6 | 0,7 | 0,7 | 1 | 1 | 1 | 1 | 0,4 | |||||||||||||||
Private limited company · Tremelo · incorporated on 12/03/2010 · 0,3 ETP
Private limited company profitable and well capitalised. Cash position rising (+7.6%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Dr. Janssen - Dr. Burin is a Private limited company incorporated in 2010. Its main activity is: Other human health activities. Its registered office is in Tremelo. It employs on average 0,3 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette